Metropolis Healthcare
METROPOLIS · NSE · Healthcare · India
Financials at a glance
Source: Yahoo FinanceAnnual
Quarterly · last 5
Revenue (FY2026)
₹1,646 Cr
Net margin
11.5%
Revenue CAGR (3y)
+12.8%
Profit CAGR (3y)
+10.0%
Net profit (FY2026)
₹190 Cr
Ask MarketChacha about METROPOLIS
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Aug 5, 2026
Metropolis Healthcare shares fell ~3% alongside a sharp broader market sell-off (Sensex down over 1,600 points), despite positive Q1 results showing ~26% YoY net profit growth; no company-specific negative catalyst identified.
Daily moves with the verified reason behind them. Education only — not investment advice.
On MarketChacha
Posts about METROPOLISFinancials
Yearly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| FY2026 | ₹1,646 Cr | ₹190 Cr | 11.5% |
| FY2025 | ₹1,331 Cr | ₹145 Cr | 10.9% |
| FY2024 | ₹1,208 Cr | ₹128 Cr | 10.6% |
| FY2023 | ₹1,148 Cr | ₹143 Cr | 12.4% |
Quarterly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| Q1 FY27 | ₹450 Cr | ₹57 Cr | 12.6% |
| Q4 FY26 | ₹425 Cr | ₹51 Cr | 12.0% |
| Q3 FY26 | ₹406 Cr | ₹41 Cr | 10.2% |
| Q2 FY26 | ₹429 Cr | ₹53 Cr | 12.3% |
| Q1 FY26 | ₹386 Cr | ₹45 Cr | 11.7% |
Figures as reported, in ₹ (crore). Source: Yahoo Finance.
Filings & announcements
2026
Disclosure Under Regulation 30 Of SEBI Listing Regulations
Disclosure under Regulation 30 of SEBI Listing Regulations
BSE8/27/2026Disclosure under Regulation 30 of SEBI Listing Regulations
BSE8/20/2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report for the 26th Annual General Meeting
BSE8/19/2026materialShareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 26th Annual General Meeting of the Company
BSE8/18/2026materialGrant of Stock Benefits
BSE8/4/2026Allotment of 18,700 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020
BSE8/4/2026Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the un-audited standalone ....
BSE7/28/2026materialLetter to Shareholders containing weblink of Annual Report for the financial year 2025-26 and 26th Annual General Meeting
BSE7/27/2026Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the financial year 2025-26
BSE7/27/2026Notice Of The 26Th Annual General Meeting For The Financial Year 2025-26
Notice of the 26th Annual General Meeting for the financial year 2025-26 to be held on August 18, 2026
BSE7/27/2026materialAnnual Report for the financial year 2025-26
BSE7/27/2026
In the news
- 7 Stocks To Buy For Long Term: Analysts recommend 5 largecap, 2 midcap scrips; Indian Hotels Company on the listZee Business · 8/30/2026
- JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upsideThe Economic Times · 8/28/2026
- Buy Metropolis Healthcare; target of Rs 675: ICICI SecuritiesMoneycontrol.com · 8/28/2026
- Metropolis Share Price Gains On ICICI Securities 'Buy' Call— Check Target PriceNDTV Profit · 8/28/2026
- Emkay Global Sets Rs 675 Target for Metropolis HealthcareWhalesbook · 8/28/2026
- Buy Metropolis Healthcare; target of Rs 675: Emkay Global FinancialMoneycontrol.com · 8/28/2026
- Metropolis Healthcare Shares Jump 4% After Transfer Of EQAS Business Division To SubsidiaryNDTV Profit · 8/28/2026
- Low-Debt Diagnostics Stocks 2026: 3 Picks ComparedUnivest · 8/27/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.